Aspira Women's Health to Present at J.P. Morgan Healthcare Conference

Ticker: AWHL · Form: 8-K · Filed: Jan 5, 2024 · CIK: 926617

Aspira Women'S Health INC. 8-K Filing Summary
FieldDetail
CompanyAspira Women'S Health INC. (AWHL)
Form Type8-K
Filed DateJan 5, 2024
Risk Levellow
Pages1
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: conference, presentation, corporate-event

TL;DR

**AWH presenting at JPM conference Jan 9th, watch for potential stock movement.**

AI Summary

Aspira Women's Health Inc. filed an 8-K on January 4, 2024, to disclose that they will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024, at 10:30 AM PT. This matters to investors because it's an opportunity for the company to share updates on its business, potentially influencing stock performance based on the information presented and investor reception.

Why It Matters

This presentation could provide crucial updates on Aspira Women's Health's strategic direction, product pipeline, or financial outlook, directly impacting investor sentiment and the stock's short-term trajectory.

Risk Assessment

Risk Level: low — This filing is a routine announcement of a conference presentation, which carries minimal direct risk to the company or its investors.

Analyst Insight

A smart investor would monitor the content of Aspira Women's Health's presentation at the J.P. Morgan Healthcare Conference on January 9, 2024, for any significant announcements that could impact future stock performance, rather than reacting solely to the announcement of the presentation itself.

Key Players & Entities

Forward-Looking Statements

FAQ

What is the purpose of Aspira Women's Health Inc.'s 8-K filing dated January 4, 2024?

The 8-K filing is to announce that Aspira Women's Health Inc. will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference.

When and where will Aspira Women's Health Inc. present at the J.P. Morgan Healthcare Conference?

Aspira Women's Health Inc. will present on January 9, 2024, at 10:30 AM PT, at the 42nd Annual J.P. Morgan Healthcare Conference.

What is the trading symbol for Aspira Women's Health Inc. and on which exchange is it registered?

The trading symbol for Aspira Women's Health Inc. is AWH, and its Common Stock is registered on the Nasdaq Capital Market.

What is the business address of Aspira Women's Health Inc. as stated in the filing?

The business address of Aspira Women's Health Inc. is 12117 Bee Caves Road, Building III, Suite 100, Austin, Texas 78738.

Under which item information categories was this 8-K filed?

This 8-K was filed under 'Regulation FD Disclosure' and 'Financial Statements and Exhibits'.

Filing Stats: 428 words · 2 min read · ~1 pages · Grade level 10.8 · Accepted 2024-01-05 16:39:44

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 4, 2024, Aspira Women's Health Inc. (the "Company") presented an overview of the Company's product pipeline status. A copy of the Slide Deck is furnished as Exhibit 99.1 to this Current Report on Form 8-K filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Slide Deck Presented by Aspira Women's Health Inc. On January 4, 2024 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASPIRA WOMEN'S HEALTH INC. Date: January 5, 2024 By: /s/ Torsten Hombeck Torsten Hombeck Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing